Based on the existing literature, serum CA15-3 can be utilized as a marker for advanced disease and even metastasis [14]. The preoperative serum levels of CA15-3 and CEA are shown to be elevated in advanced breast cancer disease with greater tumor size, lymph node metastasis, or aggressive histology. Here, CEACAM5 is linked to breast carcinoma.